Zobrazeno 1 - 10
of 953
pro vyhledávání: '"Bernard, Fortin"'
Autor:
DAIGNEAULT, DANIEL
Publikováno v:
Semaine; 6/7/2024, Vol. 20 Issue 19, p16-17, 2p, 2 Color Photographs
Publikováno v:
7 Jours; 2/24/2023, Vol. 34 Issue 18, p24-29, 6p, 4 Color Photographs
Autor:
Vanessa Di Lalla, Bernard Fortin, Catherine Pembroke, Carolyn Freeman, Michael Yassa, Tarek Hijal
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 9, Iss , Pp 13-17 (2019)
Background: Best-practice guidelines recommend single-fraction (SFRT) instead of multi-fraction radiation therapy (MFRT) for uncomplicated symptomatic bone metastases. SFRT is comparable to MFRT in relieving pain, convenient for patients, and cost-ef
Externí odkaz:
https://doaj.org/article/1400c47ae7054738baf8de9588e6a7ab
Autor:
CARDINAL, VICTOR-LÉON
Publikováno v:
Échos Vedettes; 10/7/2023, Vol. 61 Issue 41, p5-5, 1/3p, 2 Color Photographs
Autor:
Lemieux, Michèle
Publikováno v:
Semaine; 8/3/2018, Vol. 14 Issue 26, p28-31, 4p, 3 Color Photographs
Autor:
Simon Langlois
Publikováno v:
Recherches sociographiques. 39:178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::658564d1d3c68cc66aaa8e27fdd0968c
https://doi.org/10.7202/057199ar
https://doi.org/10.7202/057199ar
Autor:
Pierre P. Tremblay
Publikováno v:
Politique et Sociétés. 16:167
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db3246d7a2c336cfa53349e15021945a
https://doi.org/10.7202/040058ar
https://doi.org/10.7202/040058ar
Autor:
HAMEL, FRANÇOIS, HOULE, PIERRE-LUC
Publikováno v:
Semaine; 3/10/2023, Vol. 19 Issue 6, p7-7, 1/9p, 1 Color Photograph
Autor:
CARDINAL, VICTOR-LÉON
Publikováno v:
Échos Vedettes; 3/4/2023, Vol. 61 Issue 10, p7-7, 1/5p, 1 Color Photograph
Autor:
Guy Leblanc, M P Dufresne, Marie-Hélène Ngo, Lucas Sideris, Michael A. Yassa, David Tiberi, David Nguyen, Mai-Kim Gervais, Marie-Christine Guilbert, Pierre Dubé, Bernard Fortin, P. Vavassis
Publikováno v:
Cancer Research. 80:P4-12
Introduction: Estrogen receptor (ER)-positive/HER2-negative breast cancers are known to be less immunogenic than triple negative and HER2-positive breast cancers. As increasing levels of tumor-infiltrating lymphocytes (TILs) have been associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::995b5aa05fe0b5b8a284537a020d0b74
https://doi.org/10.1158/1538-7445.sabcs19-p4-12-07
https://doi.org/10.1158/1538-7445.sabcs19-p4-12-07